Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Differences in Plasma Cannabidiol Concentrations in Women and Men: A Randomized, Placebo-Controlled, Crossover Study
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 12, Pages 10273
Publisher
MDPI AG
Online
2023-06-19
DOI
10.3390/ijms241210273
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CBD supplementation reduces arterial blood pressure via modulation of the sympatho-chromaffin system: A substudy from the HYPER-H21-4 trial
- (2023) Marko Kumric et al. BIOMEDICINE & PHARMACOTHERAPY
- Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study
- (2023) Ana Batinic et al. Pharmaceuticals
- Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial
- (2022) Danielle McCartney et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue
- (2022) Robert B. Child et al. Nutrients
- Chronic Effects of Effective Oral Cannabidiol Delivery on 24-h Ambulatory Blood Pressure and Vascular Outcomes in Treated and Untreated Hypertension (HYPER-H21-4): Study Protocol for a Randomized, Placebo-Controlled, and Crossover Study
- (2022) Marko Kumric et al. Journal of Personalized Medicine
- Sex Differences in the Neuropsychiatric Effects and Pharmacokinetics of Cannabidiol: A Scoping Review
- (2022) Justin Matheson et al. Biomolecules
- Cannabidiol in Pharmacoresistant Epilepsy: Clinical Pharmacokinetic Data From an Expanded Access Program
- (2021) Manuela Contin et al. Frontiers in Pharmacology
- Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
- (2021) Brittney H. Davis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for cannabis-drug interactions
- (2021) Shamema Nasrin et al. DRUG METABOLISM AND DISPOSITION
- Sex differences in medical cannabis-related adverse effects
- (2021) Joshua Aviram et al. PAIN
- The Impact of Marijuana on Antidepressant Treatment in Adolescents: Clinical and Pharmacologic Considerations
- (2021) Samuel Vaughn et al. Journal of Personalized Medicine
- Sex differences in acute cannabis effects revisited: Results from two randomized, controlled trials
- (2021) Thomas R. Arkell et al. ADDICTION BIOLOGY
- Cannabis and Driving
- (2021) Godfrey D. Pearlson et al. Frontiers in Psychiatry
- The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations
- (2020) Valentina Franco et al. CLINICAL PHARMACOKINETICS
- Cannabidiol and Abnormal Liver Chemistries in Healthy Adults: Results of a Phase 1 Clinical Trial
- (2020) Paul B. Watkins et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Towards Better Delivery of Cannabidiol (CBD)
- (2020) Sophie Anne Millar et al. Pharmaceuticals
- Disposition of Cannabidiol Metabolites in Serum and Urine from Healthy Individuals Treated with Pharmaceutical Preparations of Medical Cannabis
- (2020) Ana Pilar Pérez-Acevedo et al. Pharmaceuticals
- Examination of a New Delivery Approach for Oral Cannabidiol in Healthy Subjects: A Randomized, Double-Blinded, Placebo-Controlled Pharmacokinetics Study
- (2019) Alexander Patrician et al. ADVANCES IN THERAPY
- A Novel Self-Emulsifying Drug Delivery System (SEDDS) Based on VESIsorb® Formulation Technology Improving the Oral Bioavailability of Cannabidiol in Healthy Subjects
- (2019) Katharina Knaub et al. MOLECULES
- The Pharmacokinetics and the Pharmacodynamics of Cannabinoids
- (2018) C.J. Lucas et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects
- (2018) Lesley Taylor et al. CNS DRUGS
- A Systematic Review on the Pharmacokinetics of Cannabidiol in Humans
- (2018) Sophie A. Millar et al. Frontiers in Pharmacology
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Age and sex variation in serum albumin concentration: an observational study
- (2016) Gary Weaving et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Fatty Acid-binding Proteins (FABPs) Are Intracellular Carriers for Δ9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD)
- (2015) Matthew W. Elmes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PharmGKB summary
- (2011) Stuart A. Scott et al. Pharmacogenetics and Genomics
- How important are sex differences in cannabinoid action?
- (2010) Liana Fattore et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interindividual Variation in the Pharmacokinetics of Δ9-Tetrahydrocannabinol as Related to Genetic Polymorphisms in CYP2C9
- (2008) C Sachse-Seeboth et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now